OTLK   $0.89  26.29% Market Closed After Close 0.9211 3.49%

Outlook Therapeutics, Inc.
Total Cash 32.02M
totalCashPerShare 1.354
EBITDA -61.19M
Total Debt 32.72M
quickRatio 0.753
currentRatio 1.072
Total Revenue
debtToEquity
Revenue/Share
ROA -0.83686996
ROE
grossProfits
freeCashflow -43.59M
operatingCashflow -64.55M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 150.91M
forwardPE -2.5330741
floatShares 13.53M
sharesOutstanding 23.66M
sharesShort 2.99M
sharesShortPriorMonth 2.47M
dateShortInterest
sharesPercentSharesOut 0.13%
heldPercentInsiders 0.36%
heldPercentInstitutions 0.36%
Short Ratio help_outline 10.99%
shortPercentOfFloat 0.19%
impliedSharesOutstanding
bookValue -3.575
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -94.05M
trailingEps -5.89%
forwardEps -2.57%
enterpriseToEbitda -2.47
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.85 3Q 2024
institutionsCount 90
lastUpdated Nov. 7, 2024, 2:27 a.m.